Gamida Cell Ltd. - Ordinary Shares (GMDA) Social Stream
GAMIDA CELL LTD (GMDA) Price Targets From Analysts
Use the tables below to see what analysts covering GAMIDA CELL LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 4 | $27 | $11 | $18.4 | $2.1 | 776.19% |
| 2021-11-16 | 5 | $22 | $11 | $15 | $2.1 | 614.29% |
| 2022-03-24 | 5 | $22 | $11 | $14.6 | $2.1 | 595.24% |
| 2022-04-26 | 6 | $22 | $11 | $14.6 | $2.1 | 595.24% |
| 2022-08-02 | 6 | $22 | $6 | $13.2 | $2.1 | 528.57% |
| 2022-08-16 | 5 | $22 | $6 | $13.2 | $2.1 | 528.57% |
| 2022-09-12 | 5 | $22 | $8 | $13.6 | $2.1 | 547.62% |
| 2022-09-30 | 5 | $22 | $8 | $13 | $2.1 | 519.05% |
| 2022-10-02 | 5 | $22 | $7 | $12.8 | $2.1 | 509.52% |
| 2022-11-15 | 5 | $22 | $7 | $13.25 | $2.1 | 530.95% |
| 2022-11-22 | 5 | $22 | $7 | $12 | $2.1 | 471.43% |
| 2023-02-21 | 4 | $22 | $7 | $11.75 | $2.1 | 459.52% |
| 2023-04-18 | 5 | $8 | $5 | $6.5 | $2.1 | 209.52% |
| 2023-04-20 | 5 | $11 | $5 | $7.5 | $2.1 | 257.14% |
| 2023-05-15 | 4 | $11 | $5 | $7.5 | $2.1 | 257.14% |
| 2023-05-16 | 4 | $11 | $5 | $7 | $2.1 | 233.33% |
| 2023-05-22 | 5 | $11 | $5 | $6.8 | $2.1 | 223.81% |
The Trend in the Analyst Price Target
GMDA's average price target has moved down $6 over the prior 33 weeks.
Over the past 51 weeks, GMDA's average upside potential has been 508.58%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-22 | 5 | 22 | 7 | 11.75 | 1.550 | 658.06% |
| 2023-04-18 | 5 | 8 | 5 | 6.50 | 1.690 | 284.62% |
| 2023-04-20 | 5 | 11 | 5 | 7.50 | 1.655 | 353.17% |
| 2023-05-16 | 5 | 11 | 5 | 7.00 | 2.030 | 244.83% |
| 2023-05-22 | 5 | 11 | 5 | 6.80 | 1.950 | 248.72% |
GMDA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
GMDA's average broker recommendation rating improved by 0 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GMDA as an investment opportunity.
- GAMIDA CELL LTD's upside potential (average analyst target price relative to current price) is greater than 1737.22% of all US stocks.
- GAMIDA CELL LTD's average analyst price target is higher than 252.93% of all US stocks.
- In the context of all US stocks, GAMIDA CELL LTD's variance in analysts' estimates is lower than -1505.17% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, GAMIDA CELL LTD's number of analysts covering the stock is greater than 536.5% of them.
Stocks similar to GAMIDA CELL LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMTX, GRTS, and STRO.
View All Top Stocks by Price Target
Make investment decisions regarding GMDA using the data that counts. Try POWR Ratings for free.